Abstract:Background and aim "Gain-of-function" mutations in voltage-gated sodium channel NaV1.7 have been linked to erythromelalgia (EM), characterized by painful hot and red hands and feet. We investigated the proportion of patients with EM that carry a mutation in NaV1.7 or in other pain-related genes and studied possible clinical differences. Methods In this study, 48 patients with EM were screened for mutations in a total of 29 candidate genes, including all sodium channel subunits, transient receptor potential channels (TRPA1, TRPV1, TRPM8), neurotrophic factors (NGF, NGFR, BDNF, GDNF, NTRK1 and WNK1) and other known pain-related genes (CACNG2, KCNS1, COMT, P2RX3, TAC1, TACR1), using a combination of next generation sequencing and classical Sanger sequencing. Results In 7/48 patients protein-modifying mutations of NaV1.7 (P187L, I228M, I848T (n = 4) and N1245S) were identified. Patients with the I848T mutation could be identified clinically based on early onset and severity of the disease. In contrast, there were no clinical characteristics that differentiated the other patients with NaV1.7 mutation from those patients without. We also found more than twenty rare protein-modifying genetic variants in the genes coding for sodium channels (NaV1.8, NaV1.9, NaV1.6, NaV1.5, NaV2.1, SCN1B, SCN3B), transient receptor potential channel (TRPA1, TRPV1), and other pain-related targets (WNK1 and NGFR). Conclusion We conclude that functionally characterized mutations of NaV1.7 (I848T) are present only in a minority of patient with EM. Albeit the majority of patients (27/48) carried rare protein-modifying mutations the vast majority of those will most probably not be causally linked to their disease. Implications The key question remaining to be solved is the possible role of rare variants of NaV1.8, NaV1.9, or beta-subunits in provoking chronic pain conditions or even EM.

A Gain-of-Function Mutation in TRPA1 Causes Familial Episodic Pain Syndrome

Two Novel<i>SCN9A</i>Gene Heterozygous Mutations May Cause Partial Deletion of Pain Perception

Gain-of-Function mutations in SCN11A cause familial episodic pain

Congenital insensitivity to pain: novel SCN9A missense and in-frame deletion mutations

GENES CONTRIBUTING TO PAIN SENSITIVITY IN THE NORMAL POPULATION: AN EXOME SEQUENCING STUDY

Pain perception is altered by a nucleotide polymorphism in SCN9A

Human pain channelopathies

Familial Episodic Pain Syndromes

Atypical Changes in DRG Neuron Excitability and Complex Pain Phenotype Associated with a Na(v)1.7 Mutation That Massively Hyperpolarizes Activation

CYP1B1-derived epoxides modulate the TRPA1 channel in chronic pain

A SCN10A SNP Biases Human Pain Sensitivity.

Molecular mechanism of hyperactivation conferred by a truncation of TRPA1

SCN9A mutations in paroxysmal extreme pain disorder: allelic variants underlie distinct channel defects and phenotypes

Syntaxin1A overexpression and pain insensitivity in individuals with 7q11.23 duplication syndrome

Cingulate Protein Arginine Methyltransferases 1 Regulates Peripheral Hypersensitivity Via Fragile X Messenger Ribonucleoprotein

Gain-Of-Function Na(V)1.8 Mutations in Painful Neuropathy

Sporadic Onset of Erythermalgia: A Gain-Of-Function Mutation in Na(V)1.7

Exonic mutations in SCN9A (NaV1.7) are found in a minority of patients with erythromelalgia

Novel SCN9A Missense Mutations Contribute to Congenital Insensitivity to Pain: Unexpected Correlation Between Electrophysiological Characterization and Clinical Phenotype

Genetic, Electrophysiological, and Pathological Studies on Patients with SCN9A-related Pain Disorders.

Differential Methylation of the Trpa1 Promoter in Pain Sensitivity